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Introduction: Meconium Stained Amniotic Fluid (MSAF) is a frequent finding during deliveries and is 
a cause for perinatal morbidity and mortality. Meconium Aspiration Syndrome (MAS) in neonates is an 
association in these deliveries with some infants requiring mechanical ventilation. This study was done with 
the aim of finding the risk factors for MSAF and its perinatal outcome. Methods: This was a hospital based, 
cross-sectional study. All the inborn babies delivered with MSAF were included in the study. Antenatal 
risk factors and perinatal outcomes like mode of delivery, Apgar score, NICU admission and neonatal 
morbidities mainly MAS were noted. Results: MSAF was seen in 202 (13.6%) neonates out of which 
30 (15%) developed MAS. Antenatal risk factors were present in 97 (48%) cases. Mode of delivery was 
caesarean section in 78 (39%) and instrumental in 25 (13%) cases. Twenty three percent of the neonates 
required resuscitation at birth while 34% required respiratory support. Morbidities observed were meconium 
aspiration, pneumonia, septicaemia, perinatal asphyxia, shock, meconium gastritis and persistent pulmonary 
hypertension. Neonatal mortality amongst all neonates with meconium was 1.5%. Conclusion: Meconium 
stained amniotic fluid leading to aspiration is a significant cause of neonatal mortality and morbidity. Most 
of the risk factors for MAS are preventable.
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INTRODUCTION:
 Meconium Stained Amniotic Fluid (MSAF) 
complicates delivery in approximately 8-25% of live 
births.[1] About 5% of neonates born with MSAF 
develop Meconium Aspiration Syndrome (MAS) 
and approximately 50% of these infants require 
mechanical ventilation.[1] Neonates born with 
MSAF can aspirate meconium into lungs and develop 
respiratory distress. This may lead to atelectasis, 
emphysema, pneumothorax, pneumo-mediastinum, 
pneumo-pericardium, chemical-pneumonitis or may 
progress to respiratory failure.[2]
 MSAF increases the rate of perinatal 
morbidity (3-5%) and mortality.[3]MAS is a serious 
and potentially preventable condition. Some of the 
risk factors for MAS include post-dated pregnancy, 
Small for GestationalAge (SGA), oligohydramnios, 
Hypertensive Disease of Pregnancy (HDP), 
gestational diabetes and maternal drug abuse. This 
study was therefore done with the aim of finding the 
risk factors for MSAF and its perinatal outcome in a 
tertiary care center.
METHODS:
 This was a hospital based, descriptive, 
cross sectional study conducted in Department of 
Pediatrics, Lumbini Medical College Teaching 
Hospital (LMCTH) for a duration of six months 
from 1st January 2019 to 30th June 2019. Ethical 
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approval was obtained from the Institutional 
Review Committee of the institute (IRC-LMC). 
The objective of the study was to find out the rate of 
MSAF and MAS, analyze maternal and neonatal risk 
factors, mode of delivery and neonatal morbidity 
and mortality in MSAF among women delivering at 
LMCTH.
 Sample size was calculated using the formula: 
N=  z(1-α/2)2 *p(1-p)/d2.
 Taking the incidence of meconium (p) 
as15%,[4] the minimum sample size required was 
196.
 All the neonates delivered in the obstetric 
ward of the hospital with MSAF during the study 
period were included. Informed consent was taken 
from the mother after diagnosis of MSAF. The 
neonates were followed till discharge. Still births, 
neonates with congenital malformations and, 
multiple gestations were excluded from the study.
 A performa was filled for each case after 
delivery of the baby by the attending paediatrician 
or paediatric resident. This included demographic 
characteristics of the mother and baby, antenatal 
risk factors like postdated pregnancy, anemia, HDP, 
diabetes, intrauterine growth retardation, antepartum 
hemorrhage and oligohydramnios. Need for 
induction of labour and drugs used for induction were 
also noted. The phase of labour in which meconium 
was noted was recorded along with the type of 
meconium. MSAF was diagnosed as green colored 
amniotic fluid and thick meconium was described 
as having a pea soup appearance. Also, the need of 
resuscitations like orogastric suction, bag and mask 
ventilation or endo-tracheal intubation was noted 
along with Neonatal Intensive Care Unit (NICU)
management like oxygenation, bubble Continuous 
Positive Airway Pressure (CPAP) or mechanical 
ventilation. MAS was diagnosed by the presence 
of meconium in the amniotic fluid at the time of birth 
long with respiratory distress.
 Data were entered to and analyzed by 
Statistical Package for Social Sciences (SPSSTM)
software version 21.0. Results were expressed 




Fig. 1. Total deliveries and case inclusion. 
 Out of 1478 total deliveries which included 
1099 vaginal deliveries and 379 caesarean sections, 
207 (14%) cases were with MSAF. Among them, one 
with multiple congenital anomalies and four with 
Intra-uterine Fetal Death (IUFD) were excluded and 
only 202 were selected for the study. MAS was seen 
in 14.8% of MSAF. Of all MSAF cases, 60% had 
vaginal delivery and 40% had caesarian section.
 Out of 202 pregnant ladies, teenage 
pregnancy (15-19 years) was 42 (20.7 %) and four 
(1.9%) were more than 35 years of age (Table 1). 











Gravidity Primigravida 127 (62.9)
Multigravida 75 (37.1)
Antenatal visit <4 46 (22.8)
≥4 156 (73.2)
Labour induction Yes 94 (46.5)
No 168 (53.5)








Thin meconium 113 (55.9)
MSAF detection Before onset of 
labor 20 (9.9)  
Latent phase 94 (46.5)
Active phase 41 (20.3)
Second stage 39 (19.3)
Intra operative 8 (4)
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 One hundred and eight patients had antenatal 
risk factors. Hemoglobin was less than 11gm/dl in 
28% cases.  Four cases had oligohydramnios, five 
were diabetic. Fifteen developed pre-labor rupture 
of membrane (Table 2).
Table 2. Antenatal risk factors in cases of MSAF.






Anemia (Hemoglobin<11 gm/dl) 57 (28)
HDP 9 (4.45)
PROM>18 hours 15 (7.4)
Oligohydramnios 4 (2)
Diabetes Mellitus-II 5 (2.47)
Antepartum hemorrhage 5 (2.5)
Intrauterine growth restriction 10 (4.95)
Hepatitis B positive 2 (1)
Others 1 (0.49)
PROM: Prelabor rupture of membranes 
Table 3. Clinical profile of babies with MSAF.
Parameters N %







Vaginal delivery 95 47
Emergency 
LSCS 78 38.6
Elective LSCS 4 2
Vacuum delivery 18 8.9
Forceps delivery 7 3.5
At Birth Vigorous 173 85.6
Non vigorous 29 14.4
APGAR score <4 at 1 min 13 6.4
<4 at 5 min 2 1





Sex Male 100 49.5
Female 102 50.5
Table 4. Resuscitation and respiratory support at 
birth.
Resuscitation at birth N %
None 156 77.2
Orogastric suction 11 5.5
Endotracheal suction 13 6.4
Bag and mask ventilation 17 8.4
Endotracheal ventilation 6 3
More than one technique 4 2
RespiratorySupport
None 134 66.3
Oxygen via head box/ nasal 
prongs 43 21.3
CPAP* 22 10.9
Mechanical Ventilation 3 1.5
*Continuous Positive Airway Pressure
 One hundred and sixty-two deliveries had 
weight range group of 2.5-3.5 kg. One hundred and 
twenty-nine deliveries occurred at 41-42 weeks of 
gestation. Ninety five women had vaginal deliveries 
while 78 had emergency LSCS. Seventy eight 
(38.6%) underwent emergency caesarean section. 
Thirteen percent had instrumentation with vacuum 
or forceps. APGAR score was more than 7 in 71.3% 
neonates at one minute and 94.6 neonates at five 
minutes.
 Twenty three percent (N=46) babies required 
one or more forms of resuscitation at birth. Thirty 
four percent (N=68) were put on respiratory support 
like oxygen via head-box/ nasal prongs, bubble 
CPAP, or mechanical ventilation (Table 4).
 One hundred and seventy-two (85.2%) 
babies delivered were healthy with no complications. 
Pneumonia was seen in 19 babies and four had 
septicemia. Three cases had expired (Table 5).
DISCUSSION:
 This study was conducted to find out the 
incidence and analyze the risk factors for MSAF 
and MAS. The incidence of MSAF was 13.6% in 
our study and among those babies 14.8% developed 
MAS. Similar incidence has been reported in 
another study by Dohbit JS et al.,[5] with MSAF 
being reported as 11.15% out of which 2.34% was 
MAS. The reason for low MAS in the study could 
be explained by the large sample size of more than 
2000 babies. Thirupathi RA et al.,[4] showed the 
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incidence of MAS to be 13.12% while Gurubacharya 
S et al.,[6] reported MSAF and MAS in 14.8% and 
6.6% respectively. However Addisu D et al.,[7] 
reported prevalence of MSAF 17.8% among 495 
mothers in Felege Hiwot Referral Hospital in North 
West Ethiopia which is also a low-income country 
like Nepal.
Table 5. Final diagnosis of babies born through 
MSAF their outcome.
Final Diagnosis N %
Healthy babies without 
complications 172 85.2
MAS with pneumonia 19 9.4
MAS with septicemia 4 2
Perinatal asphyxia with MAS 3 1.5
MAS with shock 2 1
MAS with meconium gastritis 1 0.5





Left against medical advice 1 0.5
PPHN: Primary Pulmonary Hypertension.
 Akhila S et al.,[8] in their study of 348 
live births in India showed MSAF in 7.13% cases. 
Lamichane A[9] reported MSAF in 7.72% and MAS 
12.20% in an 11 months study done in Western part 
of Nepal. This incidence is similar to ours as this 
institute is near to LMCTH and women might have 
similar risk factors as they are hailing from the same 
rural locality.  Similarly, Mohammad N et al.,[10] 
reported MSAF 7.84% and MAS 12% in a study in 
Pakistan. The incidence of MAS was 10/1000 live 
births in University Hospital of West Indies, Jamaica 
in a retrospective study done over five years by 
Panton et al.[11]
 Although the exact cause of MSAF is 
unclear; fetal distress, cord accidents and maternal 
hypertension have been identified as potential risk 
factors.[4] MSAF was seen in 21% of teenage 
pregnancy in our study which is higher than the 
national figure of 17% in NDHS 2016 but equivalent 
to that of rural areas (22%).[4] The study site is 
also located in the a rural area so higher the rate 
of teenage pregnancy, higher would be the rate of 
MSAF. Sixty three percent of our mothers were 
primigravidae similar to the report of Chaudhary 
R et al.[3] Primigravida and/ or teenage pregnancy 
have increased risk of prolonged labor which in turn 
may increase the risk of MSAF or MAS.[3] On the 
other hand, the rate of teenage pregnancy might also 
depend on education status of mothers. Antenatal 
visits have a role in counseling and explaining danger 
signs and identifying risk factors for MSAF. Seventy 
three percent of women with MSAF had more than 
four antenatal visits which is similar to the national 
ANC coverage data.[12]
 This study aimed to identify the risk factors 
for MSAF. Sixty four percent of mothers with 
MSAF were between 41-42 weeks while the rest 
were between 37-40 weeks of gestation in our 
study. Postdated pregnancy was seen in  30% in a 
study by  Panton et al.[11] There were no post term 
(>42 weeks) pregnancy in this study. This could be 
because women came to hospital in time and were 
more aware of pregnancy related complications and 
thus had less incidence of MSAF. Chaudhary R et 
al.,[3] in Jhanshi reported that 59% of mothers with 
MSAF were of 38-40 weeks of gestation. Post term 
pregnancy increased the risk of MAS. Maternal risk 
factors for MSAF in decreasing frequency were 
maternal age <25 years, post-dated pregnancy, 
anaemia, primipara, thick meconium, small for 
gestational age, PROM, intrauterine growth 
restriction, HDP, antepartum hemorrhage, diabetes 
and oligohydramnios.[3] HDP with MSAF is 
caused by underlying utero-placental insufficiency, 
which causes fetal hypoxia, resulting in passage of 
meconium, meconium aspiration, respiratory distress 
and its consequences.[2] Similar risk factors have 
been mentioned in studies by Chaudhary et al.,[3] 
Dohbit et al.,[5]  Avula TR et al.[4] and Gurubacharya 
S et al.[6] Maternal anemia was present in  28.2% in 
our study which is higher than that of the study by 
Chaudhary R et al.,(12.05%).[3] Nepal has a high 
prevalence of anemia so this could be the reason for 
higher rate of anemia.[12]
 Cesarean section (CS)was the mode of 
delivery in 40% cases. MSAF is the risk for neonatal 
morbidities so increased CS rate is justifiable. 
Chaudhary R et al.,[3] had 54.22% (n=45) of MAS 
babies born via CS which is similar to this study.
 Neonatal morbidities in our study in 
decreasing order of frequency were MAS pneumonia 
followed by MAS with culture positive septicemia, 
asphyxia and shock. One of the babies had mild 
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symptoms of vomiting and feed intolerance with 
meconium gastritis. One had significant pre- and 
post-ductal SpO2 difference and echocardiography 
diagnosis of PPHN. All of these signs and symptoms 
are the consequences of MAS. Similar morbidities 
like jaundice, pneumonia, birth asphyxia, and 
septicemia were reported in the study by Chaudhary 
R et al.[3] Neonatal resuscitation, neonatal asphyxia 
and neonatal infection were noted in the study 
by Dohbit J S et al.[5]. Low APGAR, low birth 
weight, intrauterine growth restriction, immediate 
resuscitation, endotracheal suctioning, nursery 
admission and MAS were seen in a study done in 
Pakistan.[10]The study by Panton L et al.[11] in 
West Indies, Jamaica reported morbidities like fetal 
distress, post dated pregnancy, emergency cesarean 
section, mechanical ventilation, bubble CPAP, 
hypoxic ischemic encephalopathy (HIE), PPHN and 
pneumothorax.
 Sixty eight (34%) of our neonates required 
respiratory support in the form of oxygen via head-
box/ nasal prongs, bubble CPAP and mechanical 
ventilation. Avula TR et al.,[4] in their study in 
a tertiary health facility  showed 42.85% of MAS 
babies required ventilation support in the form of 
CPAP and intermittent mandatory ventilation (IMV).
[4] MAS babies requiring mechanical ventilation and 
bubble CPAP were 6% and 15% respectively in the 
study by Panton L et al.[11] Bubble CPAP and IMV 
support  were required in  6-15% in other studies 
done by Edmond et al.,[13] and Shaikh et al.[14]
 MSAF is a threat to a neonatal life unless 
measures like close labour monitoring and timely 
interventions like emergency CS, effective neonatal 
resuscitation, NICU care and judicious management 
are given to save the life. Low APGAR scores at 
one and five minutes had association with thick 
meconium.[10] It was associated with fetal distress 
and mothers with HDP.
 In our study, mortality rate was 1.5%, which 
was similar to2.34% in another studydone in two 
hospitals in Cameroon by Dohbit JS et al.[5] and 4.7% 
in the study by Edmond MN et al.[13] Mortality rates 
vary from minimum mortality at0.86% in a study 
done in Maharasthra, India by Akhila S et al.[8] to as 
high as11% to 24% in studies done by Chaudhary R 
et al.,[3] Thirupathi et al.[4] and Gurubacharya S et 
al.[6]This difference could be due to the difference 
in sample size. The study with high number of study 
population have high incidence rate of MSAF and 
high mortality rate. 
 This study has a few limitations. It was conducted in 
a small population over a short time. The incidence 
of MSAF and MAS in relation to educational status 
and economical status of the mother was not studied 
but it forms a basis for prevalence of MSAF and 
MAS in a tertiary center in Nepal.  
CONCLUSION:
 Meconium aspiration syndrome is a common 
complication of meconium stained amniotic fluid. 
It is a significant yet preventable cause of neonatal 
morbidity and mortality. Identifying risk factors may 
help in timely diagnosis and interventions reducing 
the neonatal morbidity and mortality.
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